Loading...
Market
Which region in the US will have the highest uptake of BEYFORTUS® by the end of 2024?
2
Resolution / Starting Odds
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%
Sales data from Sanofi and AstraZeneca segmented by region
Story
Sanofi and AstraZeneca Win FDA Approval for BEYFORTUS® Manufacturing Line to Protect Babies
Sep 16, 2024, 05:00 PM
Sanofi and AstraZeneca have received approval from the U.S. Food and Drug Administration (FDA) for a manufacturing line dedicated to their preventive respiratory syncytial virus (RSV) therapy. The approval allows Sanofi to begin shipping BEYFORTUS® in the United States, aimed at protecting babies against RSV disease. This development marks a significant step for both companies in their efforts to combat RSV.
View original story
Similar markets
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Other regions • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Other Regions • 25%
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Other regions • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Other • 25%
Northeast • 25%
South • 25%
Midwest • 25%
West • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Africa • 25%
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%